|
🐜
|
Dried-Plasma Transport Using a Novel Matrix and Collection System for Human Immunodeficiency Virus and Hepatitis C Virus Virologic Testing
19 auth.
R. Lloyd,
D. Burns,
Joe Huong,
R. Mathis,
M. Winters,
M. Winters,
M. Tanner,
A. D. Rosa,
B. Yen‐Lieberman,
W. Armstrong,
...
A. Taege,
D. Mcclernon,
J. Wetshtein,
B. Friedrich,
M. Ferguson,
W. O'brien,
P. Feorino,
M. Holodniy,
M. Holodniy
|
4 |
2009 |
4
🐜
|
|
🐜
|
Thymosin alpha‐1 with peginterferon alfa‐2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?
12 auth.
A. Ciancio,
P. Andreone,
S. Kaiser,
A. Mangia,
M. Milella,
R. Solá,
...
S. Pol,
E. Tsianos,
A. D. Rosa,
R. Camerini,
R. McBeath,
M. Rizzetto
|
4 |
2012 |
4
🐜
|
|
🐜
|
Potent Antiviral Effect of Reverset™ in HIV-1-Infected Adults following a Single Oral Dose
10 auth.
L. Stuyver,
Tamara R. Mcbrayer,
D. Schürmann,
I. Kravec,
A. Beard,
L. Cartee,
...
R. Schinazi,
A. D. Rosa,
R. Murphy,
M. Otto
|
3 |
2003 |
3
🐜
|
|
🐜
|
Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination with Sofosbuvir in Naive Subjects with HCV Genotype 1 Short Title: Telaprevir & Sofosbuvir in HCV Genotype 1
15 auth.
G. Morelli,
R. Firpi,
Patrick M. Horne,
J. Peter,
Lucy Askushevich,
Monika Vainorius,
S. George,
A. D. Rosa,
G. P. Reddy,
Taylor J. Evers,
...
R. Arrendale,
Tara L. Kieffer,
V. Garg,
M. Fried,
D. Nelson
|
1 |
2015 |
1
🐜
|
|
🐜
|
Alone or in Combination with Pegylated Interferon-a 2 a and Ribavirin Prevents Hepatitis C Virus ( HCV ) Replication and Selection of Resistant Variants in HCV-Infected Patients
11 auth.
S. Pogam,
A. Seshaadri,
A. Ewing,
Hyunsoon Kang,
A. Kosaka,
Jun Yan,
...
M. Berrey,
B. Symonds,
A. D. Rosa,
N. Cammack,
I. Nájera
|
0 |
2010 |
0
🐜
|
